Anacor, Novartis deal

Anacor and Novartis’ Sandoz Inc. generics unit amended a 2014 deal granting Sandoz exclusive rights in the U.S. to commercialize onychomycosis drug Kerydin tavaborole. Under the amendment, Sandoz wil...